Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy-Reference-Cited by-同舟云学术

Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy

Published:2016-02-02 Issue:8 Volume:76 Page:703-714
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Akinboye Emmanuel S.¹,Brennen W. Nathaniel¹,Rosen D. Marc¹,Bakare Oladapo²,Denmeade Samuel R.¹

Affiliation:

1. Department of Oncology; Chemical Therapeutic Program; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Johns Hopkins University School of Medicine; Baltimore Maryland

2. Department of Chemistry; Howard University; District of Columbia Washington

Funder

Mass Spectrometry Core at Johns Hopkins

Publisher

Wiley

Subject

Urology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pros.23162/fullpdf

Reference43 articles.

1. The emetine alkaloids;Wiegrebe;J Nat Prod,1984

2. Structural basis for inhibition of protein synthesis by emetine and cycloheximide based on an analogy between ipecac alkaloids and glutarimide antibiotics;Grollman;Proc Natl Acad Sci USA,1966